Brokerages have assigned a consensus rating of “Hold” to AstraZeneca PLC (NASDAQ:AZN).
According to Bloomberg.com, the sixteen analysts now monitoring the firm have given the stock of AstraZeneca PLC (NASDAQ: AZN) a ...
Tag: AZN, Analyst Rating
Two Sigma Investments LP has acquired shares of AstraZeneca PLC (NASDAQ:AZN).
Two Sigma Investments LP increased the percentage of AstraZeneca PLC (NASDAQ: AZN) shares that it owned by 555.6% during the ...
Shore Capital reiterates its rating on AstraZeneca (LON:AZN).
In a research report published on Thursday, stock analysts at Shore Capital reaffirmed their "buy" rating on AstraZeneca (LON: AZN), ...
Credit Suisse AG reduces its holdings of AstraZeneca PLC (NASDAQ:AZN).
The most recent Form 13F filing that Credit Suisse AG submitted with the SEC revealed that during the third quarter, ...
Analysts at Deutsche Bank Aktiengesellschaft have set a price target of £130 on AstraZeneca (LON:AZN).
According to a report disseminated on Monday, Deutsche Bank Aktiengesellschaft has reportedly established a price target for AstraZeneca (LON: AZN) ...
Analysts at Barclays assign a £125 price target to AstraZeneca (LON:AZN).
According to analysts from Barclays, the price target for AstraZeneca (LON: AZN) has been established at £125 ($151.85), which was ...